| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > Waterborne Disease - What Is Naegleria Fowleri? |
|
E-Articles - Waterborne Disease - What Is Naegleria Fowleri?
Naegleria is an ameba that is found in the environment and Naegleria fowleri According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product is the only species found to infect humans. This ameba is most often found i ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in bodies of warm, fresh water.
Infection from Naegleria occurs when the ameb lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. enters the body through the nose. It then makes its way to the brain and sp here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe inal cord. The disease progresses rapidly and death usually results within 3 d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro to 7 days. Naegleria fowleri is very rare as infections occur in 1 per 2.6 m ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc llion. However, it should be noted that illness and death is not rare as it r easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi elates to recreational waterborne illnesses. Every summer when the water lev nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ls are low and the temperatures begin to rise over 80 degrees water becomes a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ breeding ground for infectious diseases. Today there is no cure for Naegleri ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi fowleri. However, you can avoid exposure to Naegleria and other waterborne b ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a acteria by holding the nose or using nose clips when jumping and diving into dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod resh water. Also, avoid lakes, ponds, and any pools of water that are warm a cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin d shallow.
For more information on Naegleria fowleri and the disease that ki tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen lled four-year-old Emerald Watson please visit the Center for Disease Control t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel at www.cdc.gov and search for Recreational Water Illnesses and/or Naegleria f ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust wleri. Or, follow the link at www.marshajohnson.net. (This information is n y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ot meant to be used for self-diagnosis or as a substitute for consultation wi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de h a health care provider. If you have any questions about the disease describ elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip d above or feel that you may have a parasitic infection, consult your doctor. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Choose The Office Furniture That Is Right For You Don't Try to Make Your Workers Happy Basic Auto Liability Insurance Policies
|